San Antonio Vasopressin in Shock Symposium Report

Stephen M. Cohn; Lorne H. Blackbourne; Donald W. Landry; Kenneth G. Proctor; Keith R. Walley; Volker Wenzel

doi:10.1016/j.resuscitation.2010.06.005

San Antonio Vasopressin in Shock Symposium Report

Stephen M. Cohn, Lorne H. Blackbourne, Donald W. Landry, Kenneth G. Proctor, Keith R. Walley, Volker Wenzel

Surgery

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

The San Antonio Vasopressin Symposium reviewed substantial accumulated data concerning vasopressin in haemorrhagic, septic, and cardiac arrest shock conditions and found that there is considerable evidence to support the use of vasopressin in overcoming vasopressin deficiency or insufficiency. The value of vasopressin in the setting of trauma requires further investigation. It was concluded that a large, multicenter controlled trial of vasopressin is needed to assess the therapeutic benefit of vasopressin replacement in the setting of trauma with haemorrhagic shock that is prolonged and profound.

Original language	English (US)
Pages (from-to)	1473-1475
Number of pages	3
Journal	Resuscitation
Volume	81
Issue number	11
DOIs	https://doi.org/10.1016/j.resuscitation.2010.06.005
State	Published - Nov 2010

Keywords

Cardiac arrest
Conference report
Haemorrhagic shock
Septic shock
Shock
Traumatic brain injury
Vasopressin

ASJC Scopus subject areas

Emergency Medicine
Emergency
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.resuscitation.2010.06.005

Cite this

@article{9a81f250088e4019920134fb910f2702,

title = "San Antonio Vasopressin in Shock Symposium Report",

abstract = "The San Antonio Vasopressin Symposium reviewed substantial accumulated data concerning vasopressin in haemorrhagic, septic, and cardiac arrest shock conditions and found that there is considerable evidence to support the use of vasopressin in overcoming vasopressin deficiency or insufficiency. The value of vasopressin in the setting of trauma requires further investigation. It was concluded that a large, multicenter controlled trial of vasopressin is needed to assess the therapeutic benefit of vasopressin replacement in the setting of trauma with haemorrhagic shock that is prolonged and profound.",

keywords = "Cardiac arrest, Conference report, Haemorrhagic shock, Septic shock, Shock, Traumatic brain injury, Vasopressin",

author = "Cohn, {Stephen M.} and Blackbourne, {Lorne H.} and Landry, {Donald W.} and Proctor, {Kenneth G.} and Walley, {Keith R.} and Volker Wenzel",

note = "Funding Information: The meeting was sponsored by the University of Texas Health Sciences Center, Department of Surgery, and the U.S. Army Institute of Surgical Research, San Antonio, Texas. ",

year = "2010",

month = nov,

doi = "10.1016/j.resuscitation.2010.06.005",

language = "English (US)",

volume = "81",

pages = "1473--1475",

journal = "Resuscitation",

issn = "0300-9572",

publisher = "Elsevier Ireland Ltd",

number = "11",

}

TY - JOUR

T1 - San Antonio Vasopressin in Shock Symposium Report

AU - Cohn, Stephen M.

AU - Blackbourne, Lorne H.

AU - Landry, Donald W.

AU - Proctor, Kenneth G.

AU - Walley, Keith R.

AU - Wenzel, Volker

N1 - Funding Information: The meeting was sponsored by the University of Texas Health Sciences Center, Department of Surgery, and the U.S. Army Institute of Surgical Research, San Antonio, Texas.

PY - 2010/11

Y1 - 2010/11

N2 - The San Antonio Vasopressin Symposium reviewed substantial accumulated data concerning vasopressin in haemorrhagic, septic, and cardiac arrest shock conditions and found that there is considerable evidence to support the use of vasopressin in overcoming vasopressin deficiency or insufficiency. The value of vasopressin in the setting of trauma requires further investigation. It was concluded that a large, multicenter controlled trial of vasopressin is needed to assess the therapeutic benefit of vasopressin replacement in the setting of trauma with haemorrhagic shock that is prolonged and profound.

AB - The San Antonio Vasopressin Symposium reviewed substantial accumulated data concerning vasopressin in haemorrhagic, septic, and cardiac arrest shock conditions and found that there is considerable evidence to support the use of vasopressin in overcoming vasopressin deficiency or insufficiency. The value of vasopressin in the setting of trauma requires further investigation. It was concluded that a large, multicenter controlled trial of vasopressin is needed to assess the therapeutic benefit of vasopressin replacement in the setting of trauma with haemorrhagic shock that is prolonged and profound.

KW - Cardiac arrest

KW - Conference report

KW - Haemorrhagic shock

KW - Septic shock

KW - Shock

KW - Traumatic brain injury

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=78149408355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149408355&partnerID=8YFLogxK

U2 - 10.1016/j.resuscitation.2010.06.005

DO - 10.1016/j.resuscitation.2010.06.005

M3 - Article

C2 - 20655650

AN - SCOPUS:78149408355

VL - 81

SP - 1473

EP - 1475

JO - Resuscitation

JF - Resuscitation

SN - 0300-9572

IS - 11

ER -

San Antonio Vasopressin in Shock Symposium Report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this